Madrigal Pharmaceuticals Inc (MDGL) - Financial and Strategic SWOT Analysis Review

Madrigal Pharmaceuticals Inc (MDGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Madrigal Pharmaceuticals Inc (Madrigal), formerly, Synta Pharmaceuticals Corp is a biopharmaceutical company focused on the development and commercialization of novel therapeutic candidates for the treatment of liver, cardiovascular and metabolic diseases. Its lead product candidate, MGL-3196 (orally administered), is a proprietary, liver-directed, selective thyroid hormone receptor beta, (THR-), agonist that can potentially be used for treating several disease with high unmet medical need. The company is developing MGL-3196 for non-alcoholic steatohepatitis (NASH) and familial hypercholesterolemia (FH). The company is also developing MGL-3745 (THR- agonist), a preclinical compound that has similar thyroid receptor selectivity to MGL-3196. Madrigal is also headquartered in West Conshohocken, Pennsylvania, the US.

Madrigal Pharmaceuticals Inc Key Recent Developments

May 08,2018: Madrigal Pharmaceuticals Reports 2018 First Quarter Financial Results and Reviews Key Clinical Achievements
Mar 13,2018: Madrigal Pharmaceuticals Reports 2017 Fourth Quarter and Year-End Financial Results, Reviews Key Corporate Achievements and Provides Clinical Update on MGL-3196
Nov 09,2017: Madrigal Pharmaceuticals Reports 2017 Third Quarter Financial Results
Aug 10,2017: Madrigal Pharmaceuticals Reports 2017 Second Quarter Financial Results
May 11,2017: Madrigal Pharmaceuticals Reports 2017 First Quarter Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Madrigal Pharmaceuticals Inc - Key Facts 5
Madrigal Pharmaceuticals Inc - Key Employees 6
Madrigal Pharmaceuticals Inc - Key Employee Biographies 7
Madrigal Pharmaceuticals Inc - Major Products and Services 8
Madrigal Pharmaceuticals Inc - History 9
Madrigal Pharmaceuticals Inc - Company Statement 12
Madrigal Pharmaceuticals Inc - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 Company Analysis 14
Madrigal Pharmaceuticals Inc - Business Description 14
Madrigal Pharmaceuticals Inc - Corporate Strategy 15
Madrigal Pharmaceuticals Inc - SWOT Analysis 16
SWOT Analysis - Overview 16
Madrigal Pharmaceuticals Inc - Strengths 16
Madrigal Pharmaceuticals Inc - Weaknesses 17
Madrigal Pharmaceuticals Inc - Opportunities 18
Madrigal Pharmaceuticals Inc - Threats 19
Madrigal Pharmaceuticals Inc - Key Competitors 20
Section 3 Company Financial Ratios 21
Financial Ratios - Capital Market Ratios 21
Financial Ratios - Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios - Interim Ratios 25
Financial Ratios - Ratio Charts 26
Section 4 Companys Lifesciences Financial Deals and Alliances 27
Madrigal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Madrigal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Madrigal Pharmaceuticals Inc, Recent Deals Summary 29
Section 5 Companys Recent Developments 30
May 08, 2018: Madrigal Pharmaceuticals Reports 2018 First Quarter Financial Results and Reviews Key Clinical Achievements 30
Mar 13, 2018: Madrigal Pharmaceuticals Reports 2017 Fourth Quarter and Year-End Financial Results, Reviews Key Corporate Achievements and Provides Clinical Update on MGL-3196 32
Nov 09, 2017: Madrigal Pharmaceuticals Reports 2017 Third Quarter Financial Results 34
Aug 10, 2017: Madrigal Pharmaceuticals Reports 2017 Second Quarter Financial Results 36
May 11, 2017: Madrigal Pharmaceuticals Reports 2017 First Quarter Financial Results 38
Apr 03, 2017: Madrigal Pharmaceuticals Reports 2016 Fourth Quarter and Year-End Financial Results, Reviews Key Corporate Achievements and Provides Update on Lead Clinical-stage Compound, MGL-3196 39
Section 6 Appendix 41
Methodology 41
Ratio Definitions 41
About GlobalData 45
Contact Us 45
Disclaimer 45

List Of Tables

List of Tables
Madrigal Pharmaceuticals Inc, Key Facts 5
Madrigal Pharmaceuticals Inc, Key Employees 6
Madrigal Pharmaceuticals Inc, Key Employee Biographies 7
Madrigal Pharmaceuticals Inc, Major Products and Services 8
Madrigal Pharmaceuticals Inc, History 9
Madrigal Pharmaceuticals Inc, Subsidiaries 13
Madrigal Pharmaceuticals Inc, Key Competitors 20
Madrigal Pharmaceuticals Inc, Ratios based on current share price 21
Madrigal Pharmaceuticals Inc, Annual Ratios 22
Madrigal Pharmaceuticals Inc, Annual Ratios (Cont...1) 23
Madrigal Pharmaceuticals Inc, Interim Ratios 25
Madrigal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Madrigal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Madrigal Pharmaceuticals Inc, Recent Deals Summary 29
Currency Codes 41
Capital Market Ratios 41
Equity Ratios 42
Profitability Ratios 42
Cost Ratios 43
Liquidity Ratios 43
Leverage Ratios 44
Efficiency Ratios 44

List Of Figures

List of Figures
Madrigal Pharmaceuticals Inc, Performance Chart (2013 - 2017) 24
Madrigal Pharmaceuticals Inc, Ratio Charts 26
Madrigal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Madrigal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28

Madrigal Pharmaceuticals Inc (MDGL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Madrigal Pharmaceuticals Inc (Madrigal), formerly, Synta Pharmaceuticals Corp is a biopharmaceutical company focused on the development and commercialization of novel therapeutic candidates for the treatment of liver, cardiovascular and metabolic

USD 250 View Report

Madrigal Pharmaceuticals Inc (MDGL) - Financial and Strategic SWOT Analysis Review

Madrigal Pharmaceuticals Inc (MDGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

Cannabics Pharmaceuticals Inc (CNBX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cannabics Pharmaceuticals Inc (Cannabics Pharmaceuticals), formerly Thrust Energy Corp, is a drug development company that develops cannabinoid-based therapies for cancer. The company develops High Content Screening (HCS) Platform, an automated

USD 250 View Report

Amneal Pharmaceuticals Inc (AMRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Amneal Pharmaceuticals Inc (Amneal) formerly Amneal Pharmaceuticals LLC, is an integrated specialty pharmaceutical company that produces generic, specialty and biosimilar medicines. Its product portfolio includes generic and specialty drugs in

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available